Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BMA vs SYBT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SYBT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–3 Matrix Metrics)

SYBT Overall Winner 6-Pillar Tally: BMA 2 – 3 SYBT (1 Tie) Matrix Metrics: BMA 3 – 7 SYBT

As of Nov 16, 2026, Stock Yards Bancorp, Inc. (SYBT) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BMA carries a Unified Composite Score of 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin), whereas SYBT carries 40.7/100 (SELL) at $78.03 (13.6x Forward P/E, 48.5% operating margin).

  • Defensive Composite Rating Caution: Although SYBT compares more favorably head-to-head, both BMA (39.3/100 SELL) and SYBT (40.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: BMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7); meanwhile SYBT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BMA vs SYBT
BMA NYSE
Banco Macro S.A.
Commercial Banks, Nec
$53.85
-5.29% 1D
Market Cap $3.6B
TTM Revenue $3.48B
Forward P/E 3.1x
Beta / 30D Vol 1.42β · 42% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 29.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.8%), weak momentum, RSI 31
RSI-14: 30.7 · SMA20: $59.84 · SMA50: $66.06
SYBT NASDAQ Head-to-Head Winner
Stock Yards Bancorp, Inc.
State Commercial Banks
$78.03
-1.4% 1D
Market Cap $2.5B
TTM Revenue $438M
Forward P/E 13.6x
Beta / 30D Vol 0.33β · 27% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 43.0 Fund 42.0 Flow 50.0 Mom 31.1
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.3%) with fading momentum, RSI 47
RSI-14: 47.1 · SMA20: $79.07 · SMA50: $78.26

6-Pillar Scorecard Institutional Category Breakdown (BMA 2 – 3 SYBT)

Columns: Metric · BMA · SYBT
1. Valuation Multiples BMA
Forward P/E 3.1x 13.6x
Trailing P/E 11.4x 15.3x
PEG Ratio 0.47x 1.33x
EV / Revenue 1.0x 5.6x
2. Growth & Scale SYBT
Revenue Growth (YoY) +1.2% +19.8%
Earnings Growth (YoY) +3.5% +13.8%
TTM Revenue (USD) $3.48B $438M
Market Cap $3.6B $2.5B
3. Profitability & Quality SYBT
Gross Margin 98.7% 100.0%
Operating Margin 18.0% 48.5%
Net Profit Margin 9.0% 35.8%
Return on Equity (ROE) 7.1% 13.6%
4. Balance Sheet & Cash Flow SYBT
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $64.45 Book/Sh · 7.1% ROE $40.79 Book/Sh · 13.6% ROE
Dividend Yield None (0.00%) 1.62%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 77.3% (51st %ile) 34.2% (4th %ile)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Distribution
6. R&D & Supply-Chain Moat BMA
OpEx & R&D Intensity 80.7% of Rev ($2.81B) 51.5% of Rev ($226M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Banks - Regional Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BMA (3) vs SYBT (7)
Institutional Metric BMA SYBT Criterion Row Edge
Market Capitalization
Scale
$3.6B $2.5B Larger Scale BMA
Trailing P/E Ratio
Valuation
11.4x 15.3x Lower Multiple BMA
Forward P/E Ratio
Valuation
3.1x 13.6x Lower Multiple BMA
Revenue Growth (YoY)
Growth
+1.2% +19.8% Higher Growth SYBT
Operating Margin (TTM)
Profitability
18.0% 48.5% Higher Margin SYBT
Net Profit Margin
Profitability
9.0% 35.8% Higher Margin SYBT
Return on Equity (ROE)
Capital Efficiency
7.1% 13.6% Higher ROE SYBT
52-Week Range Position
Momentum
0% ($54–$106) 60% ($62–$89) Stronger Trend SYBT
Beta / 30D Volatility
Risk Regime
1.42β · 42% Vol 0.33β · 27% Vol Lower Realized Risk SYBT
Unified Institutional Score
Composite Signal
39.3 / 100 (SELL) 40.7 / 100 (SELL) Higher Composite SYBT
Trailing 12M Revenue (USD)
Operating Scale
$3.48B $438M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
98.7% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.47x PEG · 1.0x EV/Rev 1.33x PEG · 5.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($64.45 Book/Sh · 7.1% ROE) N/A ($40.79 Book/Sh · 13.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SYBT +17.66 pp
BMA: -15.91% · SYBT: +1.75%
3M Horizon SYBT +22.45 pp
BMA: -29.22% · SYBT: -6.77%
6M Horizon SYBT +36.33 pp
BMA: -25.81% · SYBT: +10.52%
1Y Horizon SYBT +51.72 pp
BMA: -35.24% · SYBT: +16.48%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BMA vs SYBT. Trailing 12-month operating profitability (BMA 18.0% vs SYBT 48.5%) and valuation multiples (BMA 3.1x vs SYBT 13.6x Forward P/E) are benchmarked directly in Pillar 4 below.

BMA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.48B
Gross Margin98.7%
Op. Margin18.0%
ROE / Fwd P/E7.1% · 3.1x
SYBT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$438M
Gross Margin100.0%
Op. Margin48.5%
ROE / Fwd P/E13.6% · 13.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BMA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 77.3%
IV Percentile 51st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BMA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SYBT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 34.2%
IV Percentile 4th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SYBT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BMA Moat Profile Scale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $3.6B market capitalization and 18.0% operating margin.
OpEx & R&D Reinvestment 80.7% of Rev ($2.81B)
90D Engineering Disclosures 0 Published
SYBT Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $2.5B market capitalization and 48.5% operating margin.
OpEx & R&D Reinvestment 51.5% of Rev ($226M)
90D Engineering Disclosures 0 Published

Investor FAQ BMA vs SYBT Key Questions & Quantitative Answers

As of Nov 16, 2026, Stock Yards Bancorp, Inc. (SYBT) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BMA carries a Unified Composite Score of 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin), whereas SYBT carries 40.7/100 (SELL) at $78.03 (13.6x Forward P/E, 48.5% operating margin). Defensive Composite Rating Caution: Although SYBT compares more favorably head-to-head, both BMA (39.3/100 SELL) and SYBT (40.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: BMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7); meanwhile SYBT is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SYBT leads the Growth & Scale pillar: BMA posts +1.2% YoY revenue growth and +3.5% YoY earnings growth on $3.48B TTM revenue (98.7% gross margin, 18.0% operating margin), compared with SYBT at +19.8% YoY revenue growth and +13.8% YoY earnings growth on $438M TTM revenue (100.0% gross margin, 48.5% operating margin). On trailing 12-month operating scale, BMA generates $3.48B in USD-normalized revenue versus $438M for SYBT. In operating R&D and SG&A reinvestment, BMA deploys 80.7% of Rev ($2.81B) (0 90-day corporate R&D disclosures) versus 51.5% of Rev ($226M) (0 disclosures) for SYBT.

BMA screens cheaper on headline valuation multiples. BMA trades at 3.1x Forward P/E, 11.4x Trailing P/E, 0.47x PEG, and 1.0x EV/Revenue (unreported cash flow margin), whereas SYBT trades at 13.6x Forward P/E, 15.3x Trailing P/E, 1.33x PEG, and 5.6x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BMA (7.1% ROE) versus SYBT (13.6% ROE) capital efficiency.

In options market volatility and institutional positioning, BMA carries 77.3% implied volatility (51st %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.42β · 42% Vol realized risk). By comparison, SYBT carries 34.2% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.33β · 27% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.